The mechanism of anastomotic thrombosis in microvascular surgery remai
ns poorly understood. We hypothesized that thrombin activity at anasto
moses plays a major role in this process. To study this, a surgically
relevant human artery anastomosis model was used to (i) measure surfac
e thrombin activity on anastomoses and on intact vessel, (ii) determin
e the inhibitability of surface thrombin by heparin and recombinant hi
rudin (r-hirudin), and (iii) determine the anastomotic and intact vess
el binding capacity for additional thrombin. Human placental artery se
gments were placed in chambers in which 0.2 cm(2) of luminal surface w
as exposed to citrated platelet-poor plasma for 10 min at 37 degrees C
. The fibrinopeptide A (FPA) concentration (indicating the action of t
hrombin on fibrinogen) in the supernatant was then measured using an E
LISA assay. Intact vessels and anastomoses expressed equivalent thromb
in activity that could not be inhibited by heparin at a concentration
(0.3 U/ml) that is sufficient to prolong the activated partial thrombo
plastin time two-fold. Conversely, the concentration of heparin routin
ely used in intraoperative vessel irrigation solutions (50 U/ml) was a
ble to completely block thrombin activity at both sites. r-Hirudin (0.
3 heparin equivalent anti-IIa U/ml) was able to inhibit nearly all of
the thrombin activity on each site. Each site was able to bind and exp
ress the activity of additional thrombin, indicating the potential for
increased vessel thrombogenicity after local clot has formed and has
been removed. These data indicate the presence of thrombin on dissecte
d human vessels and its presence in equal amounts on intact and anasto
mosed vessels when measurement is made before blood flow resumes. Furt
hermore, vessel-associated thrombin is resistant to a standard systemi
c concentration of heparin but is susceptible to the much higher hepar
in concentration that can be delivered locally by the surgeon during v
essel irrigation. (C) 1996 Academic Press, Inc.